首页> 外文期刊>Journal of biomolecular screening: The official journal of the Society for Biomolecular Screening >Development of an Immunofluorometric, High-Capacity, Cell-Based Assay for the Measurement of Human Type I and Type II Interferons
【24h】

Development of an Immunofluorometric, High-Capacity, Cell-Based Assay for the Measurement of Human Type I and Type II Interferons

机译:一种免疫荧光测定,高容量,基于细胞的测定方法,用于测定人I型和II型干扰素。

获取原文
获取原文并翻译 | 示例
       

摘要

We have developed a cell-based 96-well microtiter plate, high throughput assay for measuring both type I and type II interferon (IFN) activity on human cells. This assay makes use of a previously described IFN-specific reporter stably expressed in human HT 1080 cells. The induction of the reporter by IFN is determined by measuring the IFN-dependent expression of CD2 on the cell surface. The cytoking-induced expression of CD2 occurs within 48 h and is measured using a time-resolved fluormetric immunoassay. The limit of detection for type I IFN is >0.4 IU/ml. Interassay and intraassay coefficients of variation were 1.1% and 1.3% for the medium control (31 IU IFN#beta#1b/ml), respectively. The limit of detection for type II IFN is >8 IU/ml, and the assay coefficients of variation are similar to those determined for type I IFNs. The level of sensitivity for this assay is comparable to other assays commonly used to measure IFN activity on cells. The current assay has an advantage over antiviral and antiproliferative assays, in that there is no requirement for the use of pathogenic virus or for determining viable cell numbers. The current assay is ideally suited for increasing sample screening and high-capacity automation, making it an excellent tool for drug discovery.
机译:我们已经开发了一种基于细胞的96孔微量滴定板,用于测量I型和II型干扰素(IFN)对人细胞的活性的高通量测定法。该测定法利用在人HT 1080细胞中稳定表达的前述IFN特异性报道分子。通过测量细胞表面CD2的IFN依赖性表达来确定IFN对报告基因的诱导。细胞因子诱导的CD2表达在48小时内发生,并使用时间分辨荧光免疫测定法进行测量。 I型IFN的检出限> 0.4 IU / ml。对于培养基对照(31 IU IFN#beta#1b / ml),测定间和测定内变异系数分别为1.1%和1.3%。 II型IFN的检出限> 8 IU / ml,测定变异系数与I型IFN的测定变异系数相似。该测定法的灵敏度水平可与通常用于测量细胞上IFN活性的其他测定法相媲美。当前的测定法优于抗病毒和抗增殖测定法,因为不需要使用病原性病毒或确定活细胞数。当前的测定非常适合用于增加样品筛选和高容量自动化,使其成为药物发现的出色工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号